Profile
| Role | See Remarks, Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Orchestra BioMed Holdings, Inc.
Updated Jul 16, 2026
Hochman David P has filed 3 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $194K. Historical track record: 4/5 stars across 5 tracked purchases.
| Role | See Remarks, Director |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★☆ (4/5) |
|---|---|
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 8000% |
| 90-day win rate | 4000% |
| Avg 5-day return | +220.81% |
| Avg 30-day return | +464.26% |
| Avg 90-day return | +2279.34% |
| Best 30-day return | +1092.44% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 3.3K | $4.02 | $13K |
| 2026-06-12 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 3.3K | $4.02 | $13K |
| 2026-06-02 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 5.0K | $3.83 | $19K |
| 2026-05-19 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 5.0K | $3.77 | $19K |
| 2026-03-27 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 32.4K | $4.57 | $148K |
| 2026-03-16 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 10.0K | $4.29 | $43K |
| 2026-02-13 | OBIO | Orchestra BioMed Holdings, Inc. | A — Grant or award | 504.0K | $0.00 | |
| 2025-09-17 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 3.3K | $2.46 | $8K |
| 2025-09-17 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 40.4K | $2.46 | $99K |
| 2025-08-21 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 6.0K | $2.49 | $15K |
| 2025-08-07 | OBIO | Orchestra BioMed Holdings, Inc. | A — Grant or award | 100.0K | $0.00 | |
| 2025-08-07 | OBIO | Orchestra BioMed Holdings, Inc. | A — Grant or award | 100.0K | $0.00 | |
| 2025-08-04 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 20.0K | $2.75 | $55K |
| 2025-06-11 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 5.7K | $3.14 | $18K |
| 2025-06-11 | OBIO | Orchestra BioMed Holdings, Inc. | F — Tax withholding / forfeiture | 34.0K | $3.14 | $107K |
| 2025-04-04 | OBIO | Orchestra BioMed Holdings, Inc. | A — Grant or award | 98.3K | $0.00 | |
| 2024-12-26 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 4.0K | $4.66 | $19K |
| 2024-12-19 | OBIO | Orchestra BioMed Holdings, Inc. | P — Open-market purchase | 5.0K | $4.91 | $25K |
Hochman David P is a corporate insider — currently tracked as See Remarks, Director of Orchestra BioMed Holdings, Inc. (OBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 7 open-market purchases ($194K) and 0 open-market sales () across all tracked filings.
Across 5 tracked purchases, Hochman David P averaged +464.3% avg 30-day return with a 8000% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hochman David P profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.